PRMT2 and RORγ expression are associated with breast cancer survival outcomes.
Oh TG, Bailey P, Dray E, Smith AG, Goode J, Eriksson N, Funder JW, Fuller PJ, Simpson ER, Tilley WD, Leedman PJ, Clarke CL, Grimmond S, Dowhan DH, Muscat GE.
Oh TG, et al.
Mol Endocrinol. 2014 Jul;28(7):1166-85. doi: 10.1210/me.2013-1403. Epub 2014 Jun 9.
Mol Endocrinol. 2014.
PMID: 24911119
Free PMC article.